Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis

British Journal of Rheumatology

Volumn 37, Issue 5, 1998, Pages 562-569

  Muller K ^a,b   Herner, E B ^a   Stagg, A ^c   Bendtzen, K ^a   Woo, P ^b  

^a University of Copenhagen   (Denmark)

^b HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Flow cytometry; Interleukin 1 receptor antagonist; Interleukin 10; Interleukin 1 ; Interleukin 6; Soluble TNF receptors; Systemic juvenile chronic arthritis; Tumour necrosis factor

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADOLESCENT; ARTICLE; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0346340916     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.5.562     Document Type: Article

References (38)

1. Bendtzen K. Cytokines and natural regulators of cytokines. Immunol Lett 1994;43:111-23.
2. Arend WP. Inhibiting the effects of cytokines in human diseases. Adv Intern Med 1995;40:365-94.
3. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
4. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
5. Woo P. Cytokines in childhood rheumatic diseases. Arch Dis Child 1993;69:547-9.
6. Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W et al. Serum cytokines in juvenile rheumatoid arthritis. Arthritis Rheum 1995; 38:211-20.
7. Müller K, Pedersen FK, Wiik A, Bendtzen K. Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Rheumatol Int 1992;12:89-92.
8. De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol 1992;10:493-8.
9. Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991;34:1158-63.
10. Rooney M, David J, Symons J, Di Giovine F, Varsani H, Woo P. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454-60.
11. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
12. van Roon JAG, van Roy LAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
13. Isomaki P, Luukainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
14. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993;54:167-227.
15. Wood PHN. Special meeting on: nomenclature and classification of arthritis in children. In: Munther M, ed. The care of rheumatic children. Basel: EULAR, 1978.
16. Steinbrocker M, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1949;140:659-62.
17. Müller K, Zak M, Nielsen S, Pedersen FK, de Nully P, Bendtzen K. In vitro cytokine production and phenotype expression by blood mononuclear cells from umbilical cords, children and adults. Pediatr Allergy Immunol 1996;7:117-24.
18. Hansen MB, Svenson M, Bendtzen K. Human anti-interleukin-1 alpha antibodies. Immunol Lett 1991; 30:133-40.
19. Herzyk DJ, Berger AE, Allen JN, Wewers MD. Sandwich ELISA formats designed to detect 17 kDa IL-1 beta significantly underestimate 35 kDa IL-1 beta. J Immunol Methods 1992;148:243-54.
20. De-Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic, juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9.
21. Prieur A-M, Kaufmann M-T, Griscelli C, Dayer J-M. Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 1987;1240-2.
22. Martini A, Ravelli A, Notarangelo LD, Maccario R, Lanfranchi A, Rondena D et al. Enhanced interleukin-1 and depressed interleukin-2 production in juvenile arthritis. J Rheumatol 1986;13:598-603.
23. Helle M, Boeije L, Aarden LA. IL-6 is an intermediate in IL-1-induced thymocyte proliferation. J Immunol 1989;142:4335-8.
24. Swaak AGJ, van den Brink HG, Aarden LA. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol 1996;25:233-8.
25. Zangerle PF, De Groote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F et al. Direct stimulation of cytokines (IL-1 beta, TNF alpha, IL-2, IFN-gamma, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 1992;4:568-75.
26. Müller K, Zak M, Nielsen S, Pedersen FK, de Nully P, Bendtzen K. Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauciand polyarticular onset juvenile chronic arthritis. Clin Exp Rheumatol 1997;15:439-44.
27. Firestein GS, Boyle D, Yu C, Paine MM, Whiseand TD, Zvaifler NJ et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37:644-52.
28. Gattorno M, Picco P, Buoncompagni A, Stalla F, Pistoia V. Tumor necrosis factor receptor p75 correlates better than p55 with disease activity in juvenile rheumatoid arthritis: comment on the article by Mangge et al. Arthritis Rheum 1996;39:883-6.
29. De-Benedetti F, Pignatti P, Massa M, Sartirana P, Ravelli A, Cassani G et al. Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. Br J Rheumatol 1997;36:581-8.
30. Giradin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM. Tumour necrosis factor in meningococcal meningitis. Immunology 1992;76:22-3.
31. Llorente L, Richaud-Patin Y, Fior R, Alcocer VJ, Wijenes J, Fourrier BM et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis. Arthritis Rheum 1994;37:1647-55.
32. Bucht A, Larsson P, Weisbrot L, Thorne C, Pisa P, Smedegard G et al. Expression of interferon-gamma, IL-10, IL-12 and transforming growth factor-beta mRNA in synovial fluid cells from patients in early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996;103:357-67.
33. Lapadula G, Iannone F, Dell'Accio F, Covelli M, Pipitone V. Interleukin-10 in rheumatoid arthritis. Clin Exp Rheumatol 1995;13:629-32.
34. Lacki JK, Klama K, Mackiewicz SH, Mackiewicz U, Muller W. Circulating interleukin-10 and interleukin-6 levels in rheumatoid arthritis patients treated with methotrexate or gold salts: preliminary report. Inflamm Res 1995;44:24-6.
35. Cicuttini FM, Byron KA, Maher D, Wooton AM, Muirden KD, Hamilton JA. Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis. Rheumatol Int 1995;14:201-6.
36. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS et al. Elevated IL-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.
37. Müller K, Hansen MB, Zak M, Nielsen S, Pedersen FK, de Nully P et al. Autoantibodies to IL-1 alpha in sera from umbilical cords, children, and adults, and from patients with juvenile chronic arthritis. Scand J Rheumatol 1996;25:164-7.
38. Bendtzen K, Hansen MB, Ross C, Poulsen LK, Svenson M. Cytokines and autoantibodies to cytokines. Stem Cells 1995;13:206-22.